Giulio Cesare Passali
Overview
Explore the profile of Giulio Cesare Passali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Corso E, Porru D, Corbo M, Montuori C, De Maio G, Mastrapasqua R, et al.
Clin Otolaryngol
. 2024 May;
49(4):481-489.
PMID: 38711363
Introduction: Management of severe chronic rhinosinusitis with nasal polyps (CRSwNP) has changed significantly in recent years, with different treatments now available including biologics and endoscopic sinus surgery (ESS), although there...
2.
Passali G, Santantonio M, Vecchioli N, Sollazzo M, Rolesi R, Marotta I, et al.
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541913
: Epistaxis, particularly in Hereditary Hemorrhagic Telangiectasia (HHT) patients, is a common otolaryngological emergency, often requiring complex management. A hierarchy of increasingly invasive interventions, from external compression of the nasal...
3.
De Corso E, Settimi S, Montuori C, Cantiani A, Corbo M, Di Bella G, et al.
Acta Otorhinolaryngol Ital
. 2023 Sep;
43(Suppl. 1):S3-S13.
PMID: 37698095
Objective: This narrative review analyses factors affecting recurrence of Chronic rhinosinusitis with nasal polyps (CRSwNP) after surgery, such as type, extension and completeness of endoscopic sinus surgery (ESS). We also...
4.
Passali D, Passali G, Damiani V, Ciprandi G
Eur Arch Otorhinolaryngol
. 2023 Jun;
280(10):4713-4714.
PMID: 37277684
No abstract available.
5.
Suppressa P, Maiorano E, Gaetani E, Matti E, Lenato G, Serio I, et al.
Intern Emerg Med
. 2023 May;
18(4):1109-1118.
PMID: 37140873
Rare Disease patients manifested high concern regarding the possible increased risk of severe outcomes and worsening of disease-specific clinical manifestation due to the impact of COVID-19. Our aim was to...
6.
Ciprandi G, Passali G, Passali D
Acta Biomed
. 2022 Dec;
93(6):e2022296.
PMID: 36533770
No abstract available.
7.
Passali G, Passali D, Ciprandi G
Int Arch Otorhinolaryngol
. 2022 Nov;
26(4):e657-e660.
PMID: 36405470
Acute upper respiratory infection (AURI) is the most common cause of postinfectious olfactory dysfunction (PIOD). We investigated the prevalence of PIOD in a large group of patients reporting persistent smell...
8.
Ciprandi G, Passali G, Passali D
Acta Biomed
. 2022 Aug;
93(4):e2022266.
PMID: 36043971
No abstract available.
9.
Rizzi A, Parrinello G, De Corso E, Tricarico L, Centrone M, Di Rienzo A, et al.
J Pers Med
. 2022 Jul;
12(7).
PMID: 35887676
Background: In order to evaluate the efficacy of intranasal mometasone furoate in patients with non-allergic rhinitis (NAR), a real-life, observational, prospective study is performed. Methods: Thirty-one patients (age 18-64 years)...
10.
Marano G, Mazza M, Di Martino L, Agostini F, Passali G, Sani G, et al.
Psychiatr Danub
. 2022 Jun;
34(2):304-305.
PMID: 35772143
No abstract available.